Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]
CSA Medical Inc.
CSA Medical raises $6.6m
Endoscopic cryo-ablation company CSA Medical has raised $6.6 million in a new financing round, according to an SEC filing. The Baltimore, Md.-based company’s main product is the TruFreeze spray cryotherapy device, designed to deliver super-cold liquid nitrogen via catheter to ablate unwanted tissue, according to CSA. The company’s latest round had 26 unlisted investors, with CSA […]
Medtech investment in MN falls back to earth | Medtech funding for the week of April 20, 2015
CSA Medical raises another $4m for cryotherapy device
Maryland’s CSA Medical said last week that it’s close to reaching a $4 million funding goal with a new debt offering.
CSA Medical closes $16M financing round
CSA Medical said it raised $16 million, closing a series C financing round led by Ascension Ventures.
The Baltimore-based medical device company manufactures advanced spray cryotherapy technology that flash freezes unwanted tissue inside the body, delivering liquid nitrogen through a catheter.
Lantheus appoints Michael Heslop to VP position | Personnel Moves
J&J veteran Donald Casey takes helm of medical segment at Cardinal Health | Personnel Moves
Cardinal Health appointed Donald Casey Jr. to lead its $9 billion medical products and services division, effective next week.
InVivo readies $10M round | Funding Roundup
Spinal injury therapy maker InVivo Therapeutics Holdings Corp. (OTC:NVIV) is preparing a $10 million offering, SEC filings show.
Details haven’t yet been made public regarding pricing, but the company expects to use the proceeds for research & development, working capital, capital expenditures and other general corporate purposes.
Diabetes: $1.8M drives research in Minnesota | Funding Roundup
Three diabetes-related research projects at the Mayo Clinic and the University of Minnesota land more than $1.8 million in state funds in a research initiative to prevent, treat and cure diabetes.
The Minnesota Partnership for Biotechnology & Medical Genomics’ Decade of Discovery’s $1.86 million grant will fund the creation of anti-obesity drugs, explore immune-based diabetes treatments and advance the development of an artificial pancreas.
Diabetes: GE invests in non-invasive continuous glucose monitors | Funding Roundup
GE Healthcare (NYSE: GE) invested an undisclosed amount into C8 Medisensors, a developer of non-invasive continuous glucose monitors for diabetic patients.
C8 aims to provide glucose monitoring that is "painless, accurate, continuous, noninvasive, and nonintrusive to your life," according to its website.
The San Jose, Calif.-based company’s glucose monitors use light spectroscopy to measure blood glucose levels without the need for frequent finger pricks.
DeVivo takes over the corner office at AngioDynamics | Personnel Moves
AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.
The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.